Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Greggi

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Oncology|February 4, 2010
Primary ovarian cancer cells are sensitive to the proaptotic effects of proteasome inhibitorsLuca Pasquini, Alessia Petronelli, Eleonora Petrucci, et al.
Journal of Medical Virology|October 26, 2006
Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian populationMaria Lina Tornesello, Maria Luisa Duraturo, Gerardo Botti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative studyStefano Greggi, Giorgia Mangili, Cono Scaffa, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancerMassimo Di Maio, Carmela Pisano, Rosa Tambaro, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 22, 2019
Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional seriesFrancesca Falcone, Nicola Normanno, Nunzia S Losito, et al.
American Journal of Obstetrics and Gynecology|December 19, 2008
Food groups and endometrial cancer risk: a case-control study from ItalyFrancesca Bravi, Lorenza Scotti, Cristina Bosetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized studyPierluigi Benedetti-Panici, Stefano Greggi, Alessandro Colombo, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) studySandro Pignata, Enrico Breda, Giovanni Scambia, et al.
Infectious Agents and Cancer|August 1, 2018
Prevalence of "unclassified" HPV genotypes among women with abnormal cytologyClorinda Annunziata, Giovanni Stellato, Stefano Greggi, et al.
Anticancer Research|August 17, 2005
Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective studyCarmela Pisano, Stefano Greggi, Rosa Tambaro, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Oncology|February 4, 2010
Primary ovarian cancer cells are sensitive to the proaptotic effects of proteasome inhibitorsLuca Pasquini, Alessia Petronelli, Eleonora Petrucci, et al.
Journal of Medical Virology|October 26, 2006
Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian populationMaria Lina Tornesello, Maria Luisa Duraturo, Gerardo Botti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative studyStefano Greggi, Giorgia Mangili, Cono Scaffa, et al.
Frontiers in Bioscience : a Journal and Virtual Library|December 22, 2005
The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancerMassimo Di Maio, Carmela Pisano, Rosa Tambaro, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 22, 2019
Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional seriesFrancesca Falcone, Nicola Normanno, Nunzia S Losito, et al.
American Journal of Obstetrics and Gynecology|December 19, 2008
Food groups and endometrial cancer risk: a case-control study from ItalyFrancesca Bravi, Lorenza Scotti, Cristina Bosetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized studyPierluigi Benedetti-Panici, Stefano Greggi, Alessandro Colombo, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) studySandro Pignata, Enrico Breda, Giovanni Scambia, et al.
Infectious Agents and Cancer|August 1, 2018
Prevalence of "unclassified" HPV genotypes among women with abnormal cytologyClorinda Annunziata, Giovanni Stellato, Stefano Greggi, et al.
Anticancer Research|August 17, 2005
Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective studyCarmela Pisano, Stefano Greggi, Rosa Tambaro, et al.
Pageof 9